So here’s my attempt to summarize the latest 2018 Clinical Practice Guidelines from Diabetes Canada (as highlighted by Dr. R. Houlden) at Talk Diabetes 2018:
Talk Diabetes 2018 was an education event presented by The Diabetes Education and Management Centre of Kingston Health Sciences Centre – Hotel Dieu Site on May 11, 2018. It was a day packed with many valuable contents to be shared among health care professionals looking for an updates in diabetes, especially with the recent release of the 2018 Diabetes Canada Clinical Practice Guidelines. Here are some notes I took:
It always get on my nerves to hear about drug shortages of important medications. Last week, I have been told that spironolactone is on back order nationwide. It is difficult to know when supply will be available again. So many clinicians need to think about a “Plan B” for patients currently taking spironolactone.
What a relief to pass my CDE exam again! I am now a certified diabetes educator for another 5 years. When I wrote my last exam five years ago, all costs and expenses were paid for by my previous employer. I had no idea how much everything would add up. This time around, I have to pay everything up front, hoping the amount will be fully or partially reimbursed by the Allied Health Professional Development Fund. Here’s a brief account of my financial investment as well as some thoughts around the journey.
I am so excited to see that the results of the CANVAS program is finally released in the New England Journal of Medicine this week. Click here for the article. The results were also shared at last week’s 77th Scientific Sessions of the American Diabetes Association in San Diego, California. So what do they say? What do they mean? How do these results translate into clinical practice?
Hypothyroidism is a common condition affecting many individuals. Symptoms of hypothyroidism can be very non-specific and include the following: fatigue, cold intolerance, constipation, and weight gain. According to Up-to-date (accessed on May 6, 2017), primary hypothyroidism is characterized by a high serum thyroid-stimulating hormone (TSH) concentration and a low serum free thyroxine (T4) concentration, whereas subclinical hypothyroidism is defined biochemically as a normal free T4 concentration with an elevated TSH concentration.
We often discuss hyperglycemia in the context of diabetes. However, we should also be cognizant that many medications cause hyperglycemia too. There are many medications that can cause blood glucose to rise via different mechanisms and present with symptoms of hyperglycemia either acutely or chronically to lead to the diagnosis of diabetes.